Effects of Exenatide on Body Weight in Patients With Hypothalamic Obesity

Trial Profile

Effects of Exenatide on Body Weight in Patients With Hypothalamic Obesity

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Exenatide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2016 Primary endpoint has not been met, (Body Weight (kg)), according to results published.
    • 02 May 2016 Results (n=10) assessing the effects of exenatide on body weight were published in the Obesity (Silver Spring, Md.).
    • 02 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top